Esperion Therapeutics (ESPR) Amortizatization of Intangibles (2013 - 2023)
Esperion Therapeutics (ESPR) reported Amortizatization of Intangibles of -$100000.0 for Q2 2023, up 50.0% on a YoY basis from -$66666.7 in Q2 2022, and down 129.5% quarter-over-quarter from $339000.0 in Q1 2023.
Esperion Therapeutics (ESPR) Amortizatization of Intangibles (2013 - 2023) Analysis & Trends
Esperion Therapeutics has reported Amortizatization of Intangibles for 11 years, with the latest figure at -$100000.0 in Q2 2023.
- For the quarter ending Q2 2023, Amortizatization of Intangibles rose 50.0% year-over-year to -$100000.0; the trailing twelve-month figure through Mar 2024 stood at -$100000.0 (down 150.25% YoY), and the FY2023 full-year result was $412000.0, up 247.67% from the prior year.
- Amortizatization of Intangibles for Q2 2023 stood at -$100000.0, down from $339000.0 in the prior quarter.
- The five-year high for Amortizatization of Intangibles was $339000.0 in Q1 2023, with the low at -$200000.0 in Q3 2019.
- Historically, Amortizatization of Intangibles has averaged -$27000.0 across 5 years, with a median of -$100000.0 in 2019.
- Annual changes were most pronounced in 2019 — Amortizatization of Intangibles sank 300.0% — and 2022, when it jumped 2266.67%.
- Esperion Therapeutics' Amortizatization of Intangibles stood at $60000.0 in 2019, then plunged by 266.67% to -$100000.0 in 2020, then soared by 88.0% to -$12000.0 in 2021, then jumped by 2266.67% to $260000.0 in 2022, then sank by 138.46% to -$100000.0 in 2023.
- The last three Amortizatization of Intangibles figures came in at -$100000.0 (Q2 2023), $339000.0 (Q1 2023), and $260000.0 (Q4 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 1.30 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | 242,000.00 |
| 10 | Esperion Therapeutics | 49.69 Mn | -118.16 Mn | 45.53 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -100,000.00 |
| Jun 30, 2023 | -100,000.00 |
| Mar 31, 2023 | 339,000.00 |
| Mar 31, 2023 | 339,000.00 |
| Dec 31, 2022 | 260,000.00 |
| Dec 31, 2022 | 260,000.00 |
| Sep 30, 2022 | -200,000.00 |
| Sep 30, 2022 | -200,000.00 |
| Jun 30, 2022 | -200,000.00 |
| Jun 30, 2022 | -200,000.00 |
| Mar 31, 2022 | -173,000.00 |
| Mar 31, 2022 | -173,000.00 |
| Dec 31, 2021 | -12,000.00 |
| Dec 31, 2021 | -12,000.00 |
| Sep 30, 2020 | -100,000.00 |
| Sep 30, 2020 | -100,000.00 |
| Jun 30, 2020 | -100,000.00 |
| Jun 30, 2020 | -100,000.00 |
| Mar 31, 2020 | 73,000.00 |
| Mar 31, 2020 | 73,000.00 |